Sandip Kapadia, the CHIEF FINANCIAL OFFICER of $HRMY, sold 20,961 shares of the company on 01-15-2026 for an estimated $752,833. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares of this class of stock. Following this trade, they now own 0 shares of this class of $HRMY stock.
$HRMY Insider Trading Activity
$HRMY insiders have traded $HRMY stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $HRMY stock by insiders over the last 6 months:
- SANDIP KAPADIA (CHIEF FINANCIAL OFFICER) has made 0 purchases and 4 sales selling 65,961 shares for an estimated $2,451,052.
- JEFFREY M. DAYNO (PRESIDENT, CEO) has made 0 purchases and 2 sales selling 25,933 shares for an estimated $1,040,102.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$HRMY Hedge Fund Activity
We have seen 161 institutional investors add shares of $HRMY stock to their portfolio, and 113 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VALOR MANAGEMENT LLC removed 5,349,829 shares (-80.8%) from their portfolio in Q3 2025, for an estimated $147,441,287
- SG AMERICAS SECURITIES, LLC added 938,783 shares (+4102.4%) to their portfolio in Q4 2025, for an estimated $35,129,259
- MARSHALL WACE, LLP removed 924,166 shares (-76.4%) from their portfolio in Q3 2025, for an estimated $25,470,014
- FMR LLC removed 841,220 shares (-17.9%) from their portfolio in Q3 2025, for an estimated $23,184,023
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 388,472 shares (+42.8%) to their portfolio in Q3 2025, for an estimated $10,706,288
- UBS GROUP AG added 342,505 shares (+213.3%) to their portfolio in Q3 2025, for an estimated $9,439,437
- NAN FUNG GROUP HOLDINGS LTD removed 341,616 shares (-92.7%) from their portfolio in Q3 2025, for an estimated $9,414,936
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$HRMY Revenue
$HRMY had revenues of $239.5M in Q3 2025. This is an increase of 28.71% from the same period in the prior year.
You can track HRMY financials on Quiver Quantitative's HRMY stock page.
$HRMY Analyst Ratings
Wall Street analysts have issued reports on $HRMY in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 01/08/2026
- Mizuho issued a "Outperform" rating on 12/01/2025
- Needham issued a "Buy" rating on 11/24/2025
- HC Wainwright & Co. issued a "Buy" rating on 11/24/2025
- Deutsche Bank issued a "Buy" rating on 09/25/2025
To track analyst ratings and price targets for $HRMY, check out Quiver Quantitative's $HRMY forecast page.
$HRMY Price Targets
Multiple analysts have issued price targets for $HRMY recently. We have seen 6 analysts offer price targets for $HRMY in the last 6 months, with a median target of $44.0.
Here are some recent targets:
- Danielle Brill from Truist Securities set a target price of $45.0 on 01/08/2026
- Graig Suvannavejh from Mizuho set a target price of $46.0 on 12/01/2025
- Ami Fadia from Needham set a target price of $42.0 on 11/24/2025
- Patrick R. Trucchio from HC Wainwright & Co. set a target price of $55.0 on 11/24/2025
- Ashwani Verma from UBS set a target price of $43.0 on 10/15/2025
- David Hoang from Deutsche Bank set a target price of $36.0 on 09/25/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
